Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
The Journal of Trauma
|
February 1, 1979
White blood cell consumption in the microcirculation after a major burn
E Eriksson, R C Straube, M C Robson
Infectious Disease Clinics of North America
|
March 1, 1992
HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis
C R Smith, R C Straube, E J Ziegler
Critical Care Medicine
|
September 29, 2000
Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome
J L Zimmerman, R P Dellinger, R C Straube, et al.
British Medical Journal (Clinical Research Ed.)
|
June 15, 1985
Illness associated with contamination of drinking water supplies with phenol
S N Jarvis, R C Straube, A L Williams, et al.
Annals of Internal Medicine
|
July 1, 1994
Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group
R V McCloskey, R C Straube, C Sanders, et al.
The Journal of Infectious Diseases
|
May 1, 1983
Adenovirus type 7b in a children's hospital
R C Straube, M A Thompson, R B Van Dyke, et al.
Critical Care Medicine
|
March 1, 1997
Influence of alterations in foregoing life-sustaining treatment practices on a clinical sepsis trial. The HA-1A Sepsis Study Group
C L Sprung, L A Eidelman, R Pizov, et al.
Critical Care Medicine
|
January 15, 1998
Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group
R P Dellinger, J L Zimmerman, R W Taylor, et al.
Journal of Clinical Microbiology
|
April 1, 1987
Peroxidase-antiperoxidase assay for rapid detection of respiratory syncytial virus in nasal epithelial specimens from infants and children
A A Jalowayski, B L England, C J Temm, et al.
The Journal of Pediatrics
|
June 1, 1993
Single-dose pharmacokinetics and safety of HA-1A, a human IgM anti-lipid-A monoclonal antibody, in pediatric patients with sepsis syndrome
M J Romano, G L Kearns, S L Kaplan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
The Journal of Trauma
|
February 1, 1979
White blood cell consumption in the microcirculation after a major burn
E Eriksson, R C Straube, M C Robson
Infectious Disease Clinics of North America
|
March 1, 1992
HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis
C R Smith, R C Straube, E J Ziegler
Critical Care Medicine
|
September 29, 2000
Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome
J L Zimmerman, R P Dellinger, R C Straube, et al.
British Medical Journal (Clinical Research Ed.)
|
June 15, 1985
Illness associated with contamination of drinking water supplies with phenol
S N Jarvis, R C Straube, A L Williams, et al.
Annals of Internal Medicine
|
July 1, 1994
Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group
R V McCloskey, R C Straube, C Sanders, et al.
The Journal of Infectious Diseases
|
May 1, 1983
Adenovirus type 7b in a children's hospital
R C Straube, M A Thompson, R B Van Dyke, et al.
Critical Care Medicine
|
March 1, 1997
Influence of alterations in foregoing life-sustaining treatment practices on a clinical sepsis trial. The HA-1A Sepsis Study Group
C L Sprung, L A Eidelman, R Pizov, et al.
Critical Care Medicine
|
January 15, 1998
Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group
R P Dellinger, J L Zimmerman, R W Taylor, et al.
Journal of Clinical Microbiology
|
April 1, 1987
Peroxidase-antiperoxidase assay for rapid detection of respiratory syncytial virus in nasal epithelial specimens from infants and children
A A Jalowayski, B L England, C J Temm, et al.
The Journal of Pediatrics
|
June 1, 1993
Single-dose pharmacokinetics and safety of HA-1A, a human IgM anti-lipid-A monoclonal antibody, in pediatric patients with sepsis syndrome
M J Romano, G L Kearns, S L Kaplan, et al.
Page
of 2